Fluticasone furoate
- Generic Name
- Fluticasone furoate
- Brand Names
- Arnuity Ellipta, Avamys, Breo Ellipta, Flonase Sensimist, Trelegy Ellipta, Veramyst
- Drug Type
- Small Molecule
- Chemical Formula
- C27H29F3O6S
- CAS Number
- 397864-44-7
- Unique Ingredient Identifier
- JS86977WNV
- Background
Fluticasone furoate is a synthetic glucocorticoid available as an inhaler and nasal spray for various inflammatory indications. Fluticasone furoate was first approved in 2007.
- Indication
Fluticasone furoate is indicated for once-daily maintenance (i.e. prophylactic) treatment of asthma in patients ≥5 years old. Fluticasone furoate is available in two combination medications - one in combination with vilanterol and one in combination with both vilanterol and umeclidinium- which are both indicated for the management of chronic obstructive pulm...
- Associated Conditions
- Asthma, Chronic Obstructive Pulmonary Disease (COPD), Perennial Allergy, Seasonal Allergies
- Associated Therapies
- -
Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen
- First Posted Date
- 2008-11-17
- Last Posted Date
- 2014-07-08
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 15
- Registration Number
- NCT00791973
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome
- Conditions
- Interventions
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2015-05-04
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 24
- Registration Number
- NCT00603044
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Intranasal Steroids and Oxymetazoline in Allergic Rhinitis
- Conditions
- Interventions
- First Posted Date
- 2008-01-02
- Last Posted Date
- 2013-12-17
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 64
- Registration Number
- NCT00584987
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Intranasal Steroids and the Nasal Ocular Response
- Conditions
- First Posted Date
- 2007-05-16
- Last Posted Date
- 2013-06-03
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 20
- Registration Number
- NCT00473915
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Study In Adults And Adolescents With Seasonal Allergic Rhinitis
- Conditions
- First Posted Date
- 2005-06-24
- Last Posted Date
- 2016-09-01
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 304
- Registration Number
- NCT00115622
- Locations
- 🇺🇸
GSK Investigational Site, San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.